Hidden cholesterol byproducts linked to both infections and chronic disease

Researchers have identified oxysterols—oxidized cholesterol compounds—as a common driver of inflammation in infections and non-communicable diseases like diabetes and heart disease. The finding could reshape how drugmakers approach treating conditions spanning infectious disease to metabolic disorders, potentially opening a single therapeutic target for multiple disease areas.

Originaltitel: Implication of Oxysterols in Infectious and Non-Communicable Inflammatory Diseases